{"nctId":"NCT03172780","briefTitle":"A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee\"","startDateStruct":{"date":"2017-05-24","type":"ACTUAL"},"conditions":["Osteoarthritis, Knee"],"count":1220,"armGroups":[{"label":"Diclofenac Sodium Gel","type":"EXPERIMENTAL","interventionNames":["Drug: Diclofenac sodium gel 1%"]},{"label":"Voltaren® Gel","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%"]},{"label":"Placebo gel","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo gel"]}],"interventions":[{"name":"Diclofenac sodium gel 1%","otherNames":[]},{"name":"Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%","otherNames":[]},{"name":"Placebo gel","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Osteoarthritis knee as per American College of Rheumatology (ACR) criteria\n* Evidence of OA with Kellgren-Lawrence grade 1-3 disease.\n* After discontinuing all pain medications, had at least moderate pain on movement (POM) for target knee\n* After discontinuing all pain medications for at least 7 days has a baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC Likert (version 3.1)) pain subscale of ≥ 9 immediately prior to randomization.\n* Able to tolerate rescue medication with acetaminophen\n* Subjects who can read and understand WOMAC pain sub scale\n\nExclusion Criteria:\n\n* Pregnancy, lactation\n* OA of Kellgren-Lawrence grade 4\n* OA pain in the contralateral knee requiring medication (OTC or prescription)\n* History of OA of either Hip or Hands\n* History of secondary OA (e.g. congenital, traumatic, gouty arthritis), rheumatoid arthritis\n* History of chronic inflammatory disease (e.g., colitis) or fibromyalgia\n* History of Drugs or Alcohol abuse within the previous year\n* Symptomatic peripheral vascular disease of the study leg\n* Any musculoskeletal condition\n* Skin disease at the application site\n* Active asthma requiring periodic treatment with systemic steroids\n* Known history of positive HIV, hepatitis C virus, or HBsAg\n* Uncontrolled hypertension\n* History of myocardial infarction, thrombotic events, stroke etc.\n* Allergy to aspirin, nonsteroidal anti-inflammatory drugs (NSAID) or acetaminophen (paracetamol).","healthyVolunteers":false,"sex":"ALL","minimumAge":"35 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change in the Total WOMAC Pain Subscale Score","description":"Mean change in the total WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain subscale score for the target knee was compared to determine the clinical equivalence of Test Drug (Diclofenac sodium gel of 1% of Mylan Inc.) with the Reference Listed Drug (RLD) (Voltaren® Gel 1% of Novartis Consumer Health, Inc.) Measure Description: Western Ontario and McMaster Universities Osteoarthritis Index WOMAC pain subscale score (pain score = min 0 to max 20), was determined by the sum of subject's responses to five questions (S1-S5) using a 5-point Likert scale (i.e., 'none'=0; 'mild'=1, 'moderate'=2; 'severe'=3; 'extreme'=4). Higher values represent worse outcome.\n\n'How much pain do you have' when 'Walking on a flat surface' (S1), 'Going up or down stairs' (S2), 'at night while in bed' (S3), 'Sitting or lying' (S4), 'Standing upright' (S5)\\].\n\nThe timepoints considered for the primary outcomes include baseline and week 4.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.3","spread":"2.64"},{"groupId":"OG001","value":"-4.6","spread":"2.64"}]}]}]},{"type":"PRIMARY","title":"Change From Baseline in WOMAC Pain Subscale Score","description":"Mean change in the total WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain subscale score for the target knee was compared to determine the superiority of the Test Drug and Reference Listed Drug (RLD) over placebo.\n\nMeasure Description: Western Ontario and McMaster Universities Osteoarthritis Index WOMAC pain subscale score (pain score = min 0 to max 20), was determined by the sum of subject's responses to five questions (S1-S5) using a 5-point Likert scale (i.e., 'none'=0; 'mild'=1, 'moderate'=2; 'severe'=3; 'extreme'=4). Higher values represent worse outcome.\n\n'How much pain do you have' when 'Walking on a flat surface' (S1), 'Going up or down stairs' (S2), 'at night while in bed' (S3), 'Sitting or lying' (S4), 'Standing upright' (S5)\\].\n\nThe timepoints considered for the primary outcomes include baseline and week 4.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.2","spread":"2.84"},{"groupId":"OG001","value":"-4.4","spread":"2.74"},{"groupId":"OG002","value":"-3.2","spread":"3.46"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":398},"commonTop":["Headache","Pyrexia","Eosinophilia"]}}}